Elicio Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ELTX and other ETFs, options, and stocks.

About ELTX

Elicio Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of cancer immunotherapies. It focuses on its Amphiphile platform for trafficking lymph nodes. 

CEO
Robert T. Connelly
CEORobert T. Connelly
Employees
32
Employees32
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
2011
Founded2011
Employees
32
Employees32

ELTX Key Statistics

Market cap
86.38M
Market cap86.38M
Price-Earnings ratio
-1.28
Price-Earnings ratio-1.28
Dividend yield
Dividend yield
Average volume
28.35K
Average volume28.35K
High today
$5.50
High today$5.50
Low today
$5.33
Low today$5.33
Open price
$5.40
Open price$5.40
Volume
12.84K
Volume12.84K
52 Week high
$10.38
52 Week high$10.38
52 Week low
$3.34
52 Week low$3.34

People also own

Based on the portfolios of people who own ELTX. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.